Neurocrine Biosciences
NBIX
#1572
Rank
A$17.10 B
Marketcap
$171.54
Share price
-2.76%
Change (1 day)
-18.02%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of December 2024 : A$1.71 Billion

According to Neurocrine Biosciences 's latest financial reports the company has A$1.71 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$1.73 B14.26%
2023-12-31A$1.51 B4.15%
2022-12-31A$1.45 B48.17%
2021-12-31A$0.98 B-5.82%
2020-12-31A$1.04 B8.78%
2019-12-31A$0.95 B3.65%
2018-12-31A$0.92 B39.81%
2017-12-31A$0.66 B54.99%
2016-12-31A$0.42 B-18.08%
2015-12-31A$0.52 B119.8%
2014-12-31A$0.23 B44.94%
2013-12-31A$0.16 B-1.86%
2012-12-31A$0.16 B32.23%
2011-12-31A$0.12 B0.81%
2010-12-31A$0.12 B109.85%
2009-12-31A$59.51 M-47.82%
2008-12-31A$0.11 B-44.41%
2007-12-31A$0.20 B-11.42%
2006-12-31A$0.23 B-37.93%
2005-12-31A$0.37 B-4.09%
2004-12-31A$0.38 B-36.17%
2003-12-31A$0.60 B40.37%
2002-12-31A$0.43 B-30.72%
2001-12-31A$0.62 B112.88%
2000-12-31A$0.29 B112.44%
1999-12-31A$0.13 B625.53%
1998-12-31A$19.1 M-21.21%
1997-12-31A$24.25 M70.49%
1996-12-31A$14.22 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.24 B-27.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.81 B 64.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$5.43 M-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.44 B 218.11%๐Ÿ‡บ๐Ÿ‡ธ USA
A$8.83 B 416.22%๐Ÿ‡บ๐Ÿ‡ธ USA
A$32.58 B 1,802.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.24 B-85.95%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.62 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA